AAIC 2025 Abstract
Impact of white matter hyperintensities on disease progression in Progressive Supranuclear Palsy‐Richardson syndrome
By Indira Ruth Garcia Cordero, Juan-Camilo Vargas-González, Blas Couto, Show 16 more authorsCarmela Maria Tartaglia
Trial in peopleBiomarkers
Abstract
Background: White matter hyperintensities (WMH) are recognized as neuroimaging biomarkers of cerebral small vessel disease; however, their clinical significance in Progressive Supranuclear Palsy‐Richardson syndrome (PSP‐RS) is poorly understood.
